An observational, multicentre study of cabazitaxel in patients with metastatic castration‐resistant prostate cancer previously treated with docetaxel (CAPRISTANA)

OBJECTIVES: To obtain routine clinical practice data on cabazitaxel usage patterns for patients with metastatic castration‐resistant prostate cancer (mCRPC) and to describe physician‐assessed cabazitaxel effectiveness, health‐related quality of life (HRQoL) and safety. PATIENTS AND METHODS: CAPRISTA...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BJU Int
Auteurs principaux: Carles, Joan, Pichler, Angelika, Korunkova, Hana, Tomova, Antoaneta, Ghosn, Marwan, El Karak, Fadi, Makdessi, Joseph, Koroleva, Irina, Barnes, Gisoo, Bury, Denise, Özatilgan, Ayse, Hitier, Simon, Katolicka, Jana
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2018
Sujets:
Urological Oncology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7379594/
https://ncbi.nlm.nih.gov/pubmed/30098093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bju.14509
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires